Weight Management

Tirzepatide 20mg

20 mg

Next-generation dual GLP-1/GIP receptor agonist offering superior weight loss and metabolic benefits compared to semaglutide with enhanced glycemic control.

$199.00

Product Information

Full Name

Tirzepatide Dual GIP/GLP-1 Agonist

Therapy Level

Intermediate

Mechanism of Action

Dual GIP/GLP-1 receptor agonist for superior metabolic control

Benefits

Strong weight loss effects (dual GIP/GLP-1 agonist)Improves glycemic control (HbA1c reduction)Reduces appetite and cravingsImproves insulin sensitivityProvides cardiometabolic protection

Best For

Weight lossMetabolic syndromeType 2 diabetesBody composition

Recommended Dosage

2.5mg-15mg weekly

Frequency

Once weekly

Starting: 2.5mg once weekly for 4 weeks (titration). Escalate by 2.5mg every 4 weeks as tolerated. Therapeutic range: 5-15mg weekly. Maximum FDA dose: 15mg weekly. Any time of day.

Cycle Length

Continuous (chronic therapy)

FDA-approved use is ongoing, not cyclical. Weight-loss clinics: patients often stay on 6-12 months or longer depending on goals and tolerability.

Break Period

No defined breaks

Meant as continuous therapy in medical practice.

Common Uses

Strong weight loss effects (dual GIP/GLP-1 agonist)Improves glycemic control (HbA1c reduction)Reduces appetite and cravingsImproves insulin sensitivityProvides cardiometabolic protection

FDA Status

FDA-approved for Type 2 diabetes (Mounjaro) and weight management (Zepbound)

Contraindications

⚠️ Family history of MTC
⚠️ Family history of MEN2
⚠️ Personal history of pancreatitis

Monitoring Parameters

Monitor weight lossTrack metabolic markersWatch for GI effects

Required Lab Tests

🔬 HbA1c
🔬 Blood glucose
🔬 Lipid panel

Gelling Tendency

None

Additional Notes

Dual GIP/GLP-1 agonist. More potent than semaglutide for weight loss. CONTRAINDICATION: Family history of MTC/MEN2.

Product Details

Dual GLP-1 and GLP Receptor Agonist

Tirzepatide is a synthetic peptide that acts as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It has been studied for its ability to support healthy blood sugar regulation, improve insulin sensitivity, and promote clinically meaningful weight reduction.

Key Benefits

Supports balanced glucose metabolism
Enhances insulin sensitivity
Reduces appetite and caloric intake
Slows gastric emptying to promote satiety
Supports significant body weight reductions

Scientific Highlights

Dual GIP/GLP-1 receptor activation leads to synergistic metabolic effects
Demonstrated robust improvements in HbA1c and fasting glucose levels in clinical studies
Associated with substantial and sustained reductions in body weight

Contents: 20 mg active ingredient per vial This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.